The Indaron formulation methodology operates across six documented stages — from initial research sourcing through independent batch verification. Each stage is archived and accessible to individuals during the consultation process.
Every Indaron formulation begins in the published nutritional literature. The specialist maintains a rolling review of peer-reviewed research on micronutrient intake in physically active men across the 25–50 age range, with particular reference to Southeast Asian population data where available.
Reference sources are logged with publication date, authorship, and methodology summary. Research selections are weighted toward studies with documented population samples and independently verified intake data, rather than industry-sponsored literature.
Ingredient selection applies three sequential criteria. First, the ingredient must appear in at least two independent peer-reviewed studies for the relevant nutrient function. Second, the form selected must correspond to the bioavailability data available for the identified population group. Third, the combination of selected ingredients must be reviewed against known nutrient interaction patterns.
Ingredient profiles are finalised as a written composition document before supplier engagement begins. This document specifies the exact form, concentration range, and acceptable substitution criteria for each selected ingredient.
Active ingredients are sourced from documented suppliers, with each batch accompanied by a certificate of composition. Sourcing prioritises suppliers whose facilities maintain food-grade processing standards, with documented chain-of-custody records from raw-ingredient origin through to final formulation input.
Supplier assessments are reviewed on an annual basis and updated when supply chain changes are identified. Where a supplier cannot provide complete chain-of-custody documentation, they are excluded from the approved sourcing list regardless of ingredient cost or availability.
Each ingredient is incorporated at a concentration level referenced against the daily reference value for active men, cross-checked with the bioavailability data identified during ingredient selection.
The complete ingredient set is reviewed against a nutrient interaction matrix before assembly. Known absorption-rate interactions (such as iron and calcium timing effects) are accounted for in the composition sequence.
A finalised composition document is produced for every formulation, specifying ingredient name, form, concentration, sourcing reference, and applicable nutrient function descriptor per the Indaron vocabulary standard.
Ingredient profiles in Indaron supplements are selected based on published nutritional research and undergo independent batch verification for quality and labelling accuracy. Verification is performed by a third-party analytical facility with no financial relationship to Indaron.
Verification reports are archived per production batch and referenced by a batch code printed on each product unit. The code allows traceability from finished product back to the sourcing documentation stage.
Each batch report covers: composition accuracy against stated label values, absence of undisclosed contaminants, and conformity with food-supplement labelling standards applicable in Indonesia.
Formulation profiles are reviewed against updated nutritional research on a rolling schedule aligned with the major publication cycles in nutrition science. When material changes to the evidence base are identified — such as revised reference intakes or new bioavailability data — the relevant formulation enters a formal revision process.
Revision notes are archived with date, triggering reference, and a summary of changes applied. The Indaron formulation history is maintained as a continuous document that reflects the development of the evidence base over time rather than a static specification.
Individuals who have received a formulation recommendation from the Indaron specialist are notified of material composition revisions when they occur. Minor adjustments below the 10% concentration threshold are logged but do not trigger individual notification.
New publications affecting ingredient selection criteria are logged each quarter.
Every formulation revision is archived with date, trigger reference, and change summary.
Material revisions are communicated directly to individuals with active formulation recommendations.
Full methodology documentation, including batch verification reports and sourcing records, is available to individuals following a scheduled nutrition review.